Results 31 to 40 of about 7,902 (150)

SABR

, 2018
State-of-the-art software-defined wide area networks (SD-WANs) provide the foundation for flexible and highly resilient networking. In this work, we design, implement, and evaluate a novel architecture (denoted as SABR) that leverages the benefits of ...
Michael Zink, Divyashri Bhat, Amr Rizk, Ralf Steinmetz   +3 more
core   +1 more source

Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial

Journal for ImmunoTherapy of Cancer
Background The recent phase II randomized stereotactic ablative radiotherapy with and without immunotherapy (I-SABR) trial has shown improved event-free survival (EFS) when adding immunotherapy to stereotactic ablative radiotherapy (SABR) for early-stage
Vivek Verma, Jianjun Zhang, John V Heymach, Joe Y Chang, Steven H Lin, Saumil Gandhi, J Jack Lee, Caroline Chung, Jia Wu, Xinyan Xu, Muhammad Aminu, Natalie I Vokes, Eman Showkatian, Qasem Al-Tashi, Morteza Salehjahromi, Sheeba J Sujit, Yuliya Kitsel, Zhongxing Liao, Maliazurina B Saad, Muhamed Qayati Mohamed, David Qian, David Jaffray   +21 more
doaj   +1 more source

NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial

Contemporary Clinical Trials Communications, 2023
Background: Surgery remains the standard of care for localised renal cell carcinoma (RCC). Nevertheless, nearly 50% of patients with high-risk disease experience relapse after surgery, with distant sites being common.
Muhammad Ali, Simon Wood, David Pryor, Daniel Moon, Mathias Bressel, Arun A. Azad, Catherine Mitchell, Declan Murphy, Homi Zargar, Nick Hardcastle, Jamie Kearsley, Renu Eapen, Lih Ming Wong, Katharine Cuff, Nathan Lawrentschuk, Paul J. Neeson, Shankar Siva   +16 more
doaj   +1 more source

Daily adaptive MR-guided stereotactic ablative re-irradiation (re-SABR) in oligometastatic liver disease: A single-institution retrospective analysis

Clinical and Translational Radiation Oncology
Objective: Stereotactic ablative body radiotherapy (SABR) is an established treatment option in oligometastatic liver disease. Limited data exist on liver SABR re-irradiation (re-SABR).
Elena Moreno-Olmedo, Dan Murray, Ben George, Paul Bassett, Andy Gaya, Veni Ezhil, Somnath Mukherjee, Rebecca Muirhead, Ramanivas Sundareyan, Peter Dickinson, James Good, Kasia Owczarczyk   +11 more
doaj   +1 more source

Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial

, 2022
Purpose: SABR may improve survival in patients with oligometastases, but for some lesions, safe delivery of SABR may require a reduction in delivered dose or target coverage.
Olson, Robert, Gaede, Stewart, Palma, David A., Symes, Kerry, Verbakel, Wilko F. A. R., Warner, Andrew, Bergman, Alanah, Thomas, Christopher G., Bowes, David, Senan, Suresh, Chng, Nick, Basran, Parminder, Harrow, Stephen, Gagne, Isabelle, Huang, Vicky, Ward, Lucy, van Oirschot, Matthew, Houston, Peter   +17 more
core   +1 more source

"Pricing Average Options on Commodities" [PDF]

This paper proposes a new approximation formula for pricing average options on commodities under a stochastic volatility environment. In particular, it derives an option pricing formula under Heston and an extended lambda-SABR stochastic volatility ...
Kenichiro Shiraya, Akihiko Takahashi
core   +2 more sources

Swaption pricing with SABR model [PDF]

, 2020
The purpose of this Master’s thesis is to present the SABR and shifted SABR models and perform a calibration procedure on the Euribor and Libor swaptions’ volatility cube.
Danielyan, Karen
core  

Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy, 2019
Michael Mix,1 Sean Tanny,1 Tamara Nsouli,1 Ryan Alden,1 Rishabh Chaudhari,2 Russell Kincaid,1 Paula F Rosenbaum,3 Jeffrey A Bogart,1 Paul Aridgides1 1Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; 2Department ...
Mix M, Tanny S, Nsouli T, Alden R, Chaudhari R, Kincaid R, Rosenbaum PF, Bogart JA, Aridgides P   +8 more
doaj  

Stereotactic ablative radiotherapy for patients with hepatocellular carcinoma: analysis of post-treatment radiology and explant histology

BJC Reports
Background Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment modality for hepatocellular carcinoma (HCC). Evaluation of tumour responses following SABR are currently based on conventional radiological criteria used for locoregional
Nekisa Zakeri, Ramanivas Sundareyan, Owen Cain, James Good, Tahir Shah, Shishir Shetty   +5 more
doaj   +1 more source

Utvidgningar av SABR-modellen till negativa räntor

, 2017
In this report, we present extensions of the SABR model to negative rates applied to the swaption market. We start by briefly presenting the classical SABR model. Then we study the Shifted, Free Boundary and Mixture SABR Models. Numerical experiments are
Jamjam, Najib
core   +2 more sources